RMH Holdings Limited (8437) AI Stock Analysis

• Market Cap: HK$10.32M
• Dividend Yield: N/A
• Average Volume (3M): 33.87K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.98
• Revenue Growth: 14.64%
• EPS Growth: -81.95%
• Country: HK
• Employees: 45
• Sector: Healthcare
• Sector Strength: 51
• Industry: Medical - Care Facilities
• EPS (TTM): -0.03
• Shares Outstanding: 66,600,000
• 10 Day Avg. Volume: 69,000
• 30 Day Avg. Volume: 33,866
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 41 Neutral
• Price Target: HK$0.00 ▼(-100.00% Downside)

The overall stock score is heavily impacted by significant financial challenges, including declining revenues and negative equity. While there is some short-term positive momentum, the overbought RSI and negative valuation metrics highlight the stock's risks. Strategic improvements are necessary for a positive outlook.

RMH Holdings Limited Business Overview & Revenue Model

Company Description

RMH Holdings Limited, an investment holding company, provides medical, dermatological, and aesthetic products and services in Singapore, Hong Kong, and internationally. The company operates in two segments, Healthcare service and Trading sales. It provides specialty care services for various dermatological conditions affecting skin, hair, and nails through medical, surgical, laser, and aesthetic treatments. The company also engages in treating skin cancer and skin diseases, such as eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts; and providing consultancy, prescription, and dispensing services. In addition, it engages in the trading of health supplement products and medical products, including hand sanitizers, disposal medical masks, and other medical products. The company operates seven dermatology and surgery clinics, one aesthetic and laser center, one multi-specialists center, and one regenerative medicine center. RMH Holdings Limited was incorporated in 2017 and is headquartered in Singapore.

How the Company Makes Money

RMH Holdings Limited generates revenue mainly through its aesthetic medical services. The company charges clients for various cosmetic and dermatological procedures, which include non-invasive treatments, surgical procedures, and skin care consultations. Additionally, RMH Holdings earns income from the sale of specialized skin care products tailored to enhance the results of its aesthetic treatments. The company may also benefit from strategic partnerships with technology providers and cosmetic suppliers that aid in expanding its service offerings and enhancing operational efficiency.

RMH Holdings Limited Financial Statement Overview

Summary

RMH Holdings Limited faces significant financial challenges, with declining revenues and persistent losses. The balance sheet is unstable with negative equity, and cash flows are insufficient to meet financing needs. Financial restructuring and operational improvements are critical.

Income Statement

RMH Holdings Limited shows a consistent decline in revenue from 2019 to 2024, with significant negative EBIT and net income in recent years. The gross profit margin is positive, but net profit margins are severely negative, indicating operational inefficiencies and high costs. Revenue growth remains negative, reflecting challenges in maintaining sales momentum.

Balance Sheet

The balance sheet reflects a concerning financial structure with negative stockholders' equity and high total liabilities exceeding assets, indicating potential insolvency risks. The debt-to-equity ratio is non-meaningful due to negative equity, emphasizing financial instability. The equity ratio is negative, further highlighting balance sheet weaknesses.

Cash Flow

Operating cash flow has improved slightly but remains low relative to net income, indicating cash flow issues. Free cash flow has shown improvements, but the free cash flow to net income ratio remains weak. Despite minor improvements, cash flow generation is inadequate to cover financing needs.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	5.04M	3.18M	4.24M	10.29M	7.81M
Gross Profit	3.15M	1.54M	707.00K	8.01M	5.12M
EBITDA	-2.60M	-5.00M	-7.84M	-2.59M	-6.47M
Net Income	-3.51M	-6.75M	-24.95M	-8.79M	-9.27M
Balance Sheet
Total Assets	3.97M	4.15M	12.40M	18.91M	20.49M
Cash, Cash Equivalents and Short-Term Investments	566.00K	306.00K	2.12M	2.75M	4.93M
Total Debt	4.28M	258.00K	2.86M	11.06M	11.76M
Total Liabilities	28.38M	16.67M	18.69M	14.34M	14.96M
Stockholders Equity	-19.50M	-12.41M	-6.29M	4.57M	5.53M
Cash Flow
Free Cash Flow	113.00K	368.00K	-6.41M	-7.33M	-6.64M
Operating Cash Flow	114.00K	781.00K	-5.09M	-6.13M	-4.51M
Investing Cash Flow	142.00K	1.52M	-3.28M	-506.00K	-6.69M
Financing Cash Flow	-4.00K	-2.46M	6.65M	3.82M	3.47M

RMH Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.16
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8437, the sentiment is Neutral. The current price of 0.16 is above the 20-day moving average (MA) of 0.15, above the 50-day MA of 0.16, and below the 200-day MA of 0.19, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.98 is Neutral, neither overbought nor oversold. The STOCH value of 86.49 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:8437.

RMH Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2293	75 Outperform	HK$221.35M	9.26	10.72%	4.55%	-22.12%	-28.95%
8357	60 Neutral	HK$109.82M	―	-10.31%	―	-11.68%	-71.01%
8161	58 Neutral	HK$18.30M	2.27	105.83%	―	-8.48%	―
8307	56 Neutral	HK$86.49M	―	-44.60%	―	-8.20%	-10.39%
Sector *	51 Neutral	$7.86B	-0.26	-41.41%	2.22%	22.87%	-2.01%
8143	46 Neutral	HK$156.69M	―	-18.22%	―	-58.63%	40.85%
8437	41 Neutral	HK$10.32M	―		―	14.64%	-81.95%